Clinical trial
A Phase II Study to Assess Changes in Physical Function in Elderly Patients With…
NCT00210795 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Terminated
Key facts
| NCT number | NCT00210795 |
|---|---|
| Title | A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia |
| Official title | A Randomized, Double-blind, Placebo-controlled, Study to Assess Changes in Physical Function in Elderly Patients With Anemia of Chronic Disease (ACD) Receiving Epoetin Alfa (PROCRIT) |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Collaborators | Ortho Biotech Products, L.P. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Aged, Hemoglobins |
| Intervention type | Drug |
| Interventions | epoetin alfa |
| Enrollment | 12 |
| Start date | Jun 1, 2004 |
| Completion | Oct 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 10, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: